| abstract |
Disclosed is a drug having a prophylactic or therapeutic effect on organ fibrosis in humans. Collagen-producing myofibroblast-like of hepatic stellate cells by preparation of parapoxvirus obtained from strains D1701, orf-11, Greek orf 176, Greek orf 155, and New Zealand (NZ) Demonstrates the effect on the final pathway common to all diseases that lead to fibrosis, utilizing inhibition of transformation to type. [Selection figure] None |